They explore the essentials of effective AI policies, including defining covered technologies, distinguishing between AI tools, and establishing governance. Key safeguards, regulatory developments, vendor diligence, and bias auditing are discussed, along with practical topics like AI transcription, employee disclosure, and role-specific training. Listeners gain actionable guidance for creating adaptable, compliant AI policies. The discussion highlights real-world challenges organizations face and offers strategies to integrate AI policies with existing compliance frameworks. Whether new to AI or refining current policies, this episode provides timely insights for navigating a rapidly evolving landscape.

They discuss the most common pitfalls of employee AI use, including inadvertent disclosure of confidential information, model “hallucinations,” and source opacity, that undermine auditability and accuracy. Turning to HR functions, they examine emerging regulatory frameworks and compliance expectations, such as bias auditing requirements for automated employment decision tools and accessibility obligations, alongside practical steps for vetting vendors, embedding human oversight, and enforcing contractual protections. Listeners will come away with pragmatic strategies to update policies, document decisions and foster a transparent culture of accountability that will position organizations to leverage AI use that is smarter, not riskier.

Stay tuned for future episodes where we will explore the use of AI in human resources, privacy implications and cybersecurity issues, AI in executive compensation & employee benefits, among other topics.

Ropes & Gray provides a comprehensive suite of legal services for retail alternatives, including fund formation, registration and compliance, structuring of public-private investment solutions, tax planning, and ongoing regulatory and transactional support. For additional information, please visit our Alternative Retail Funds page, which includes a library of our thought leadership resources with insights on the latest market developments.

• The DEA’s potential rescheduling of cannabis and the ongoing administrative hearing process.
• Updates on telemedicine flexibilities for prescribing controlled substances, including new rules and proposed regulations.
• Latest enforcement developments from the DOJ related to controlled substance prescribing via telemedicine, including notable cases and implications for the future.

Tune in for an insightful conversation on these critical topics and stay informed about the latest legal and regulatory changes in the life sciences and health care industries. 

• Federal oversight: recent federal initiatives, including the FTC’s workshop and the impact of new legislation targeting private equity.
• State regulations: an overview of expanding state-level health care transaction laws, including notable developments in Massachusetts, California, New York and the Midwest.
• Enforcement trends: insights into how these regulations are being enforced, and their impact on deal timelines and administrative costs.
• Strategic implications: how investors can navigate these new requirements, potential challenges, and strategies for adapting to this regulatory environment.

Stay tuned for part two, where they will dive deeper into the responsibilities that employers should be mindful of when considering, evaluating and monitoring PEPs, as well as recent regulatory changes impacting PEPs

On this opening episode, health care partner Stephanie Webster moderates a discussion with health care partners Adrianne Ortega and Jenn Romig on why joint ventures have become increasingly popular in the health care industry as well as current trends in joint ventures.

On this opening episode, asset management counsel Catherine Skulan hosts the first of a two-part conversation between Brad Flint, partner and co-lead of Ropes & Gray’s venture investing & emerging companies practice, and Raj Banerjee, a senior associate in that practice. Brad and Raj discuss down rounds and their alternatives, including recapitalizations when a down round isn’t enough. Their discussion also sheds light on evolving and emerging terms that are becoming increasingly common in today’s deal landscape.

Please stay tuned for the second part of their conversation, where they will cover the emergence of additional terms and investor protection mechanisms recently taking root in the market. 

The episode is hosted by Michael Littenberg, Ropes & Gray partner and global head of the ESG, CSR and business and human rights practice. Michael is the only private practice attorney listed as a contributor in the guidance. He also is quoted in the publication.

On this podcast, Ropes & Gray thought leaders come together for a timely in-depth discussion of the most recent anti-ESG developments and the demands asset managers are navigating. During the podcast, they discuss fiduciary duties, antitrust, proxy advisors, state legislation, greenwashing and consumer protection claims and ERISA considerations. The participants provide concrete compliance tips. They also provide their predictions for the future.

Ropes & Gray partners Josh Lichtenstein, Samer Musallam, Chong Park, Amy Roy and Rob Skinner share their thoughts. The discussion is moderated by Michael Littenberg, partner and global head of the firm’s ESG, CSR and business & human rights practice.

The series will examine how the adoption of new state competition, quality, access and cost laws is creating additional burdens on health care entities, including private equity-backed entities and management services organizations, that are considering new transactions—and how to mitigate the impact of these potential impediments.

On this opening episode, Ropes & Gray health care partners Debbie Gersh, Tim McCrystal and Jenn Romig discuss the impact on health care transactions of current federal and state activity (legislative and regulatory) focused on competition, broadening access, reducing cost and improving quality.